Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer-Reference-Cited by-同舟云学术

Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer

Published:2019-07 Issue:1 Volume:76 Page:59-68
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Efstathiou Jason A.,Mouw Kent W.,Gibb Ewan A.,Liu Yang,Wu Chin-Lee,Drumm Michael R.,da Costa Jose Batista,du Plessis Marguerite,Wang Natalie Q.,Davicioni Elai,Feng Felix Y.,Seiler Roland,Black Peter C.,Shipley William U.,Miyamoto David T.

Funder

National Cancer Institute

Burroughs Wellcome Fund

Bladder Cancer Advocacy Network

Publisher

Elsevier BV

Subject

Urology

Reference31 articles.

1. Bladder cancer—version 3;National Comprehensive Cancer Network,2018

2. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline;Chang;J Urol,2017

3. ICUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder;Gakis;Eur Urol,2013

4. SPARE Trial Management Group. Life and death of spare (selective bladder preservation against radical excision): reflections on why the spare trial closed;Huddart;BJU Int,2010

5. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233;Mak;J Clin Oncol,2014

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose radiation-induced immunogenic cell death of bladder cancer cells leads to dendritic cell activation;PLOS ONE;2024-09-04

2. Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer Patients;International Journal of Molecular Sciences;2024-06-07

3. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer;eBioMedicine;2024-06

4. Terapia trimodal para el cáncer de vejiga: ¿es ahora el estándar para la enfermedad músculo-invasiva?;Actas Urológicas Españolas;2024-06

5. Is trimodal therapy the current standard for muscle-invasive bladder cancer?;Actas Urológicas Españolas (English Edition);2024-06